Pierre N. Tariot, MD, is Professor of Psychiatry, Medicine, and Neurology at the University of Rochester Medical Center in New York. He is also Director of Psychiatry, and Director of the Program in Neurobehavioral Therapeutics, and Co-Director of the University of Rochester Geriatric Neurology and Psychiatry Clinic, all at Monroe Hospital in Rochester, New York.

Dr Tariot is a Phi Beta Kappa graduate of Amherst College who attended the University of Rochester School of Medicine and Dentistry, completed residencies in internal medicine and psychiatry at the University of Wisconsin Hospitals in Madison, and is board certified in both specialties. He then completed a fellowship at the National Institute of Mental Health (NIMH), Bethesda, Maryland. He is the recipient of several awards and honors, including the American Geriatrics Society New Investigator Award for Neuroscience and the NIMH Geriatric Mental Health Academic Award.

Dr Tariot has worked as principal investigator in numerous research studies and is active as Chairman of the Medical Advisory Committee for the Rochester Chapter of the Alzheimer's Association. In addition, he has lectured internationally on diagnosis and therapy for dementia and Alzheimer's disease, behavioral disturbances in long-term care settings, and treatment of depression in the elderly.

Dr Tariot has published more than 150 articles, books, chapters, monographs, letters, and abstracts on these topics and is an ad hoc reviewer for several publications, including the American Journal of Geriatric Psychiatry, Alzheimer Disease and Associated Disorders, and the New England Journal of Medicine. He is a member of the American Geriatrics Society, American College of Neuropsychopharmacology, Gerontological Society of America, and American Psychiatric Association, and is a founding member of the International College of Geriatric Psychoneuropharmacology.

Dr Tariot has disclosed the following relationships:

• Grants/Research Support: Abbott Laboratories, AstraZeneca, Eisai Inc., Eli Lilly and Company, Forest Pharmaceuticals, Inc., Janssen Pharmaceutica, Novartis Pharmaceuticals Corporation, Pfizer Inc

• Consultant: Abbott Laboratories, AstraZeneca, Eisai Inc., Eli Lilly and Company, Forest Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc

• Speakers' Bureau: AstraZeneca, Janssen Pharmaceutica, Pfizer Inc